Navigation Links
Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
Date:9/12/2013

w Jersey I-95 corridor, which is the home for numerous U.S. biopharmaceutical organizations, including Merck and Johnson & Johnson.  The introduction of key ESI researchers who will lead the development and commercialization of next-generation diagnostics will occur through follow-on disclosures.

At present, Aethlon is preparing to launch the first U.S. studies of the Hemopurifier® as a therapy to address hepatitis c virus (HCV) based on the recent approval of an Investigational Device Exemption (IDE) by the United States Food and Drug Administration (FDA).  The Hemopurifier is a first-in-class device that targets the rapid elimination of infectious disease and cancer glycopathogens, including exosomes from circulation.  Exosomes enhance disease progression of viral infections and in cancer trigger apoptosis of immune cells and have been reported to facilitate tumor growth, metastasis, and the development of drug resistance. 

Aethlon will contribute diagnostic related technology to ESI, including the Enzyme Linked Lectin Specific Assay (ELLSA), which has been validated to identify the presence of exosomes underlying the human immunodeficiency virus (HIV), tuberculosis (TB), and various forms of cancer, including ovarian, melanoma, breast, lymphoma, and colorectal. ELLSA was originally created by Aethlon researchers as a tool to help validate the ability of the Hemopurifier® to capture tumor-secreted exosomes.  At the time, effective tools to isolate and quantify exosomes did not exist as few labs conducted exosome research.  Since then, an increased understanding of the role of exosomes underlying a wide-range of disease conditions has created a demand for related diagnostic products.  As part of the relationship, ESI has agreed to assign any therapeutic related discoveries back to Aethlon Medical.  Beyond the potential for future technology advances by ESI researchers, ESI may also in-license rela
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical to Present at Exosomes and Circulating Biomarkers 2013 Summit
2. Aethlon Medical Announces the Appointment of Chetan S. Shah, M.D. to its Board of Directors
3. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
4. Aethlon Medical (AEMD) Note: New Government Contract, Resubmission of IDE to Treat Hepatitis C (HCV), Biothreat Legislation Signed into Law by President Obama
5. Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer
6. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
8. Aethlon Medical Discloses CEO Interview
9. Aethlon Medical (AEMD) Note: Extracorporeal Methods to Reduce Inflammation in Sepsis
10. Aethlon Medical To Present Today At The 15th International Conference On Dialysis
11. Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 26, 2014 Lexicon Pharmaceuticals, Inc. ... completion of previously announced concurrent financing transactions resulting ... and estimated offering expenses, Lexicon anticipates net proceeds ... transactions consisted of: , a public ... to a registration statement that has been declared ...
(Date:11/26/2014)... 26, 2014 Scott Steiger lives in ... world. As an engineer for the past 20 years, he,s traveled ... military service. He,s been to six of the seven continents. Travel ... - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... has a pretty good idea of what,s required. His ...
(Date:11/26/2014)... 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical company ... infectious diseases, announced today the addition of ... opinion leader in the areas of pneumonia and ... Founder and Chief Executive Officer, Vu ... extensive experience investigating bacterial toxins and key mechanisms ...
Breaking Medicine Technology:Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... Sequenom, Inc. (Nasdaq: SQNM ) today announced that ... U.S. District Court for the Southern District of California ... in the class action securities lawsuits consolidated under the caption ... No. 3:09-cv-00921 LAB-WMC.  A copy of the stipulation of settlement is ...
... MOUNTAIN VIEW, Calif. , May 5 Alexza Pharmaceuticals, Inc. (Nasdaq: ... King will present during The Ninth Annual JMP Securities Research Conference.  The ... 8:00 am PT .  The presentation will be webcast from the Ritz Carlton ... , , ...
Cached Medicine Technology:Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit 2Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference 2Alexza Pharmaceuticals to Present at The Ninth Annual JMP Securities Research Conference 3
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... suffer from an embarrassing fact of life, and she ... musty a few minutes later, I decided that there ... longer periods," she said. , Easy to use and ... maintains freshness in a woman’s private areas throughout the ...
(Date:11/27/2014)... Most babies and young children don,t need medicines if ... Administration says. Over-the-counter (OTC) cold and cough medicine ... because they could cause serious and potentially deadly side ... three colds a year, but children get them more ... to give them pain relievers, decongestants and other medicines, ...
(Date:11/27/2014)... New York, NY (PRWEB) November 27, 2014 ... devoted to offering stylish, comfortable and high functioning compression socks, ... line. The newly-released socks use an innovative Gradient Pressure (TM) ... freshly oxygenated blood. , VIM & VIGR’s commitment to adding ... thought of as just functional recently caught the eye of ...
(Date:11/27/2014)... 27, 2014 Two international trainers and ... procedure will help one person with significant needs but ... Jivraj and Dr. Mamaly Reshad of the Anacapa Dental ... launched a website devoted to helping dentist learn about ... website would be devoted to helping a patient who ...
(Date:11/27/2014)... Aliso Viejo, California (PRWEB) November 27, 2014 ... have announced a new plugin entitled ProPip, taking FCPX to ... picture in picture effect with a few clicks of a ... is a time saver that our users will appreciate.” , ... with full customization leaving the possibilities truly endless. ProPip is ...
Breaking Medicine News(10 mins):Health News:Steer Clear of Cold Meds for Babies, FDA Advises 2Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 2Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 3Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 4Health News:World-Renowned Oxnard All-on-4™ Dental Implants Experts to Give Away Full Mouth Rehabilitation Annually 5Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 2Health News:Pixel Film Studios released ProPip plugin Exclusively for Final Cut Pro X 3
... years,since the nation,s capital was stunned by terrorist ... are we any better prepared now than we,were ... Hospital,Center will answer the question, Tuesday evening, October ... READY?" -- as they present the,Washington Hospital Center,s ...
... Renowned Therapist Challenges Modern Psychology and Explodes Myths of ,Why ... ... children have a,genetic predisposition to bad behavior and are more difficult to ... parents, has,been the cross parents have had to bear for decades, placing ...
... October 29, 2007 - A new study published in ... self-reported active epilepsy and health-related quality of life among ... data collected in the 2003 California Health Interview Survey ... finds that in 2003, almost 300,000 (1.2 percent) adults ...
... - Monthly blog will appear in conjunction with ... 29 The Kellogg School,of Management at Northwestern ... monthly blog developed by David Dranove, the Kellogg ... Management.,"Code Red" is accessible at the following link:, ...
... (Amex: PRZ ), one of the nation,s leading ... announced that at its,2007 Annual Meeting of Stockholders held ... of board members and the,ratification of Brimmer, Burek & ... ending December 31, 2007. Re-elected board members, who ...
... Pharmaceuticals,Inc., which discovers and develops novel antiviral therapeutics ... of Steven D.,Skolsky as its President and Chief ... of the Board of Directors. "Sequoia is ... as Steven Skolsky," said Chris Mirabelli, Chairman of ...
Cached Medicine News:Health News:Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Kellogg School of Management Announces 'Code Red' 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 2Health News:PainCare Announces Results of 2007 Annual Meeting of Stockholders 3Health News:Sequoia Pharmaceuticals Announces Appointment of Steven D. Skolsky as Chief Executive Officer 2
Immersion Oil, 150 cs...
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Immersion oil for microscopy...
... DF is the highest resolution of ... and it also exhibits extremely low ... has virtually zero fluorescence and therefore ... of choice when low levels of ...
Medicine Products: